Cipla Limited

NSE: CIPLA BSE: CIPLA

NSE
1,457.45 33.50 (2.35%)

Prev Close

1423.95

Open Price

1431

Volume

1,772,625

Today Low / High

1426 / 1469.8

52 WK Low / High

1317.25 / 1702.05

Range

1,385 - 1,530

Upper Circuit (5%)

1,530.32

Lower Circuit (5%)

1,384.58

BSE
1,458.15 34.20 (2.40%)

Prev Close

1423.95

Open Price

1439.95

Volume

64,857

Today Low / High

1425.2 / 1469.95

52 WK Low / High

1317.6 / 1702

Range

1,385 - 1,531

Upper Circuit (5%)

1,531.06

Lower Circuit (5%)

1,385.24

The stock performance of Cipla Limited on both the NSE and BSE. On the NSE, the stock is priced at ₹1457.45 (target range: ₹1,385 - ₹1,530), reflecting a slight increase of 2.35%, with a trading volume of 1,772,625 shares. On the BSE, the stock is trading at ₹1458.15 (target range: ₹1,385 - ₹1,531), up by 2.40% with a volume of 64,857 shares. Both exchanges show similar low and high prices, with NSE at ₹1426 - ₹1469.8 and BSE at ₹1425.2 - ₹1469.95 The 52-week range stands at ₹1702.05 - ₹1317.25 on both exchanges. Both NSE and BSE show positive movement, indicating an upward stock trend—an appealing opportunity for growth-focused investors.

Cipla Limited Chart Graph

Comprehensive Overview of Cipla Limited

ISIN

INE059A01026

Industry

Drug Manufacturers - General

Vol.Avg

2,203,698

Market Cap

1,177,057,024,300

Last Dividend

13

Range

1317.25-1702.05

Official Website

Visit Website

IPO Date

1996-01-01

DCF Diff

-1,344.69

DCF

2,806

In-Depth Stock Rating for CIPLA

Metric Value Recommendation
Overall Rating A- Buy
DCF Score 5 Strong Buy
ROE Score 4 Buy
ROA Score 5 Strong Buy
Debt-to-Equity (DE) Score 4 Buy
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 2 Sell

Latest Dividend Details for CIPLA

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2024-08-02 August 02, 24 13 13 2024-08-02 2024-09-19
2023-07-21 July 21, 23 8.5 8.5 2023-07-21 2023-09-09
2022-08-08 August 08, 22 5 5 2022-08-10 2022-09-25
2021-08-09 August 09, 21 5 5 2021-08-10 2021-09-24
2020-03-19 March 19, 20 1 1 2020-03-20 2020-04-11 2020-03-12

Comprehensive Annual Financial Performance Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2024-03-31 25,774.09 Cr 9,043.95 Cr 16,730.14 Cr 0.6491 430.46 Cr 1,058.99 Cr 10,570.99 Cr 4,121.55 Cr 51.05 6,719.51 Cr 0.1599
2023-03-31 22,473.18 Cr 8,252.28 Cr 14,220.90 Cr 0.6328 385.39 Cr 928.14 Cr 4,007.78 Cr 2,801.91 Cr 34.72 5,131.71 Cr 0.1247
2022-03-31 21,632.76 Cr 9,229.72 Cr 12,403.04 Cr 0.5733 265.68 Cr 811.97 Cr 3,562.70 Cr 2,516.75 Cr 31.20 4,572.26 Cr 0.1163
2021-03-31 18,996.83 Cr 8,020.38 Cr 10,976.45 Cr 0.5778 132.73 Cr 705.19 Cr 3,249.31 Cr 2,404.87 Cr 29.82 4,436.35 Cr 0.1266
2020-03-31 16,703.58 Cr 6,609.38 Cr 10,094.20 Cr 0.6043 354.52 Cr 781.92 Cr 2,119.98 Cr 1,546.52 Cr 19.19 3,465.05 Cr 0.0926

Essential Financial Ratios Every Investor Must Know

Comprehensive Annual Balance Sheet Overview

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2024-03-31 640.07 Cr 32,717.82 Cr 5,915.49 Cr 26,706.4300 Cr 559.41 Cr -80.66 Cr 5,237.95 Cr 6,171.11 Cr 135.42 Cr 58.85 Cr -1,050.56 Cr 5,245.7700 Cr
2023-03-31 627.63 Cr 29,463.28 Cr 5,749.74 Cr 23,407.7800 Cr 803.12 Cr 175.49 Cr 5,156.43 Cr 5,679.95 Cr 1,774.19 Cr 52.11 Cr 573.54 Cr 5,109.6700 Cr
2022-03-31 677.74 Cr 27,101.12 Cr 5,983.74 Cr 20,841.6900 Cr 1,055.78 Cr 378.04 Cr 5,350.24 Cr 5,547.30 Cr 1,865.22 Cr 51.46 Cr 678.78 Cr 4,913.2100 Cr
2021-03-31 793.29 Cr 25,151.89 Cr 6,566.30 Cr 18,326.5300 Cr 2,014.41 Cr 1,221.12 Cr 4,669.18 Cr 5,527.11 Cr 1,828.42 Cr 63.61 Cr 423.68 Cr 4,591.5500 Cr
2020-03-31 742.38 Cr 23,662.56 Cr 7,605.28 Cr 15,763.0000 Cr 3,089.20 Cr 2,346.82 Cr 4,377.60 Cr 5,549.05 Cr 1,499.01 Cr 67.48 Cr 454.50 Cr 4,393.1400 Cr

Annual Financial Cash Flow Statement Overview

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2024-03-31 4,133.9100 Cr -2,988.0300 Cr -1,200.4300 Cr 2,784.6100 Cr -48.9900 Cr 512.3400 Cr -1,098.2500 Cr 4,121.5500 Cr -300.4600 Cr -686.1700 Cr -61.8600 Cr
2023-03-31 3,237.6500 Cr -2,388.5100 Cr -958.2900 Cr 2,054.7600 Cr -96.7800 Cr 561.3300 Cr -1,182.8900 Cr 4,220.7700 Cr -351.9000 Cr -403.5000 Cr 110.7700 Cr
2022-03-31 3,325.9000 Cr -1,871.8800 Cr -1,599.7900 Cr 2,624.7500 Cr -132.3200 Cr 658.1100 Cr -701.1500 Cr 3,675.3900 Cr -1,133.3100 Cr -403.3500 Cr -621.1100 Cr
2021-03-31 3,755.2000 Cr -2,387.1800 Cr -1,329.9000 Cr 2,936.2800 Cr 50.9100 Cr 793.2900 Cr -818.9200 Cr 3,290.0600 Cr -1,035.5900 Cr 0.0000 Cr -254.3200 Cr
2020-03-31 3,068.4500 Cr 104.0400 Cr -2,948.8200 Cr 2,068.4400 Cr 234.0200 Cr 742.3800 Cr -1,000.0100 Cr 2,178.1800 Cr -1,811.9400 Cr -664.2000 Cr -331.5500 Cr

Quarterly Financial Performance Highlights

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2024-09-30 7,051.02 Cr 3,762.63 Cr 3,288.39 Cr 0.4664 1,613.85 Cr 1,302.53 Cr 16.13 2,076.20 Cr 0.1847
2024-06-30 6,693.94 Cr 3,633.79 Cr 3,060.15 Cr 0.4572 1,469.12 Cr 1,177.64 Cr 14.58 1,715.80 Cr 0.1759
2024-03-31 6,163.24 Cr 3,422.69 Cr 2,740.55 Cr 0.4447 1,027.52 Cr 939.04 Cr 11.63 1,565.19 Cr 0.1524
2023-12-31 6,505.66 Cr 2,219.53 Cr 4,286.13 Cr 0.6588 1,698.73 Cr 1,055.90 Cr 13.08 1,737.34 Cr 0.1623
2023-09-30 6,589.22 Cr 2,313.09 Cr 4,276.13 Cr 0.6490 1,620.03 Cr 1,130.91 Cr 14.01 1,910.07 Cr 0.1716

Comprehensive Quarterly Financial Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2024-09-30 797.80 Cr 7,910.40 Cr 8,708.20 Cr 0.00 Cr 5,572.86 Cr 20,945.21 Cr 6,216.58 Cr 34,655.28 Cr 6,199.50 Cr
2024-06-30 -7,970.95 Cr 15,941.90 Cr 7,795.87 Cr 0.00 Cr 0.00 Cr 7,795.87 Cr 0.00 Cr 0.00 Cr -26,802.33 Cr
2024-03-31 874.97 Cr 4,807.01 Cr 5,681.98 Cr 4,770.66 Cr 5,237.95 Cr 19,392.45 Cr 5,933.29 Cr 32,717.82 Cr 5,915.49 Cr
2023-12-31 -4,890.69 Cr 9,781.38 Cr 4,890.69 Cr 0.00 Cr 0.00 Cr 4,890.69 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-09-30 799.84 Cr 6,374.81 Cr 7,174.65 Cr 0.00 Cr 5,470.12 Cr 19,007.47 Cr 5,609.94 Cr 31,377.09 Cr 6,281.93 Cr

Quarterly Cash Flow Statement: A Detailed Financial Overview

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2024-06-30 1,177.64 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 939.04 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-12-31 1,055.90 Cr 466.86 Cr 0.00 Cr 0.00 Cr 466.86 Cr 1,646.77 Cr 1,179.91 Cr 0.00 Cr 466.86 Cr
2023-09-30 1,130.91 Cr 580.08 Cr 0.00 Cr 0.00 Cr 580.08 Cr 1,179.91 Cr 599.83 Cr 0.00 Cr 580.08 Cr
2023-06-30 995.70 Cr 478.42 Cr 0.00 Cr 0.00 Cr 478.42 Cr 1,119.70 Cr 641.28 Cr 0.00 Cr 478.42 Cr

Historical Stock Splits Overview

Date Label Split Ratio
2006-04-24 April 24, 06 5:2
2004-05-11 May 11, 04 5:1
1999-10-18 October 18, 99 3:1

Executive Profiles

Global Chief Medical Officer
Dr. Jaideep A. Gogtay M.D., Ph.D.

Gender: Not Specified

Year Born: 1967

MD, Global Chief Executive Officer & Executive Director
Mr. Umang Vohra B.E., M.B.A.

Gender: male

Year Born: 1971

Global Chief Financial Officer
Mr. Ashish Adukia

Gender: male

Year Born:

Compliance Officer & Company Secretary
Mr. Rajendra Kumar Chopra

Gender: male

Year Born:

President & Global Chief Scientific Officer
Mr. Pradeep Bhadauria

Gender: male

Year Born:

Chief Information Officer
Ms. Sneha Hiranandani B Com

Gender: female

Year Born:

Senior Vice-President of Corporate Communications
Ms. Heena Kanal

Gender: female

Year Born:

Head of Investor Relations
Ms. Diksha Maheshwari

Gender: female

Year Born:

President & Global Chief People Officer
Dr. Raju Sunil Mistry M.A., Ph.D.

Gender: Not Specified

Year Born: 1965

Senior Vice President & Head of Corporate Finance
Mr. Dinesh Ramniranjan Jain

Gender: male

Year Born:

Frequently Asked Questions about Cipla Limited

The CEO of the company is Mr. Umang Vohra B.E., M.B.A..

The current trading price of the stock is ₹1,457.45.

The 52-week price range of this stock is ₹1317.25-1702.05.

The market capitalization of the company is ₹117,705.70 crores.

The dividend yield represents the percentage of a company stock price paid out as dividends annually. For example, if the dividend yield is 0.89%, it means the company pays this percentage of its stock price as a dividend each year.

The P/E ratio is a measure of a company stock price relative to its earnings per share (EPS). For this stock, the current P/E ratio is 26.30.

The company operates in the Healthcare sector.

The current price of Cipla Limited is ₹1,457.45. If the stock takes a bullish turn, you can expect the target price to be around ₹1,530.32. On the other hand, if the market turns bearish, the target price could drop to approximately ₹1,384.58.

The company, Cipla Limited (ISIN: INE059A01026), is a leading player in the Drug Manufacturers - General sector in India. With a market capitalization of ₹117,705.70 crores and an average daily trading volume of 2,203,698 shares, it is actively engaged in the Drug Manufacturers - General industry. The company recently declared a dividend of 13."

Scroll to Top
Save your Brokerage Now! Open Free Demat Account